Clinical Trial Update: Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating the combination of docetaxel and estramustine in patients with metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Emcyt (estramustine) (estramustine)
• Taxotere (docetaxel) (docetaxel)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN